Is global cancer care losing its human touch?

A new Lancet Oncology Commission highlights a growing “human crisis” in cancer care. Despite advances in treatment and increased survival rates, many patients worldwide are not receiving the compassionate, holistic support they need. The article, “The human crisis in cancer: a Lancet Oncology Commission,” is published in The Lancet Oncology.

Globally, more than 19 million new cancer cases were diagnosed in 2022, with projections indicating a 75% increase over the next three decades. The Commission report emphasizes that systemic issues—such as rising cancer prevalence, underfunded psychosocial services, and rapid technologization—are contributing to patients and families feeling unseen and unheard.

Health care professionals are also experiencing emotional and moral distress, manifesting as burnout and moral injury. This is particularly acute in resource-limited and conflict-affected settings.

The Commission argues that this crisis is a matter of choice, driven by how health systems define success, and advocates for a shift toward a human-centered model of cancer care. Evidence-based interventions such as early palliative care, financial protection, and culturally sensitive mental health services are scalable and cost-effective approaches; however, they remain underutilized globally.

The report outlines seven key recommendations, including redefining success metrics, ensuring equitable access, reforming medical education, and aligning technology and policy with compassionate care principles. The authors call for immediate action to embed the human experience at the core of cancer care.